AEGiS-FDA: (FDA) Latex Allergies Focus of Government Conference Food and Drug AdministrationImportant note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.
Click here to return to FDA main menu
DonateNow
Print this Article


(FDA) Latex Allergies Focus of Government Conference

Food and Drug Administration, U.S. Department of Health and Human Services - October 26, 1992
Sharon Snider, (301) 443-3285


Federal government scientists, medical professionals and industry representatives will meet Nov. 5-7 in Baltimore, Md., to discuss allergic reactions to latex medical devices.

"International Latex Conference: Sensitivity to Latex in Medical Devices," sponsored by the Food and Drug Administration, the Centers for Disease Control and the National Institutes of Health, will take place at the Hyatt Regency Baltimore at the Inner Harbor.

Reports of allergic reactions to latex devices such as surgical gloves and catheters have increased in recent years. These reactions occur in latex-sensitive people and appear to result from numerous exposures to latex proteins that are natural elements of the rubber. The reactions range from minor skin irritation to anaphylactic shock that can lead to death.

In March 1991, FDA issued a Medical Alert to health care professionals warning them of the possibility of such reactions and advising them to use non-latex materials in patients who are sensitive to latex.

The conference will seek to determine which proteins cause the reactions, identify people who are likely to be sensitive to latex and find ways to prevent allergic reactions.

For conference registration information, contact Crosspaths Management Systems Inc., Two Wisconsin Circle, Suite #660, Chevy Chase, Md. 20815, telephone 1-800-527-2847.
921026
FD921001


SOURCE: Food and Drug Administration (FDA).

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .